Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongxieanchangfang is a traditional Chinese medicine (TCM) formula used primarily for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) and related gastrointestinal disorders. The name translates to "Formula for Relieving Diarrhea and Calming the Intestines." It typically consists of a combination of herbal ingredients such as Bai Zhu (Atractylodes macrocephala), Bai Shao (Paeonia lactiflora), Chen Pi (Citrus reticulata peel), and Fang Feng (Saposhnikovia divaricata). The mechanism of action is based on TCM principles, aiming to harmonize the liver and spleen, regulate qi, relieve pain, and stop diarrhea. Modern studies suggest it may modulate gut motility, reduce visceral hypersensitivity, and exert anti-inflammatory effects in the gastrointestinal tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tongxieanchangfang.